Cory Alvey Selected Research

Therapeutics

10/2023	Selective MCL-1 inhibitor ABBV-467 is efficacious in tumor models but is associated with cardiac troponin increases in patients.
1/2017	Engineering macrophages to eat cancer: from "marker of self" CD47 and phagocytosis to differentiation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Cory Alvey Research Topics

Disease

5	Neoplasms (Cancer) 10/2023 - 01/2017
1	Multiple Myeloma 10/2023
1	B-Cell Lymphoma (Lymphoma, B Cell) 10/2023
1	Glioblastoma (Glioblastoma Multiforme) 04/2021
1	Carcinoma (Carcinomatosis) 01/2018
1	Acidosis 01/2018
1	Rupture 01/2017

Drug/Important Bio-Agent (IBA)

3	Proteins (Proteins, Gene)FDA Link 10/2023 - 01/2017
1	venetoclaxIBA 10/2023
1	TroponinIBA 10/2023
1	ErbB Receptors (EGF Receptor)IBA 04/2021
1	epidermal growth factor receptor VIIIIBA 04/2021
1	Temozolomide (Temodar)FDA LinkGeneric 04/2021
1	AntigensIBA 04/2021
1	Biomarkers (Surrogate Marker)IBA 04/2021
1	Immunoconjugates (Immunoconjugate)IBA 04/2021
1	depatuxizumab mafodotinIBA 04/2021
1	Drug CombinationsIBA 01/2018
1	Tretinoin (Retinoic Acid)FDA LinkGeneric 01/2018
1	Paclitaxel (Taxol)FDA LinkGeneric 01/2018
1	MicellesIBA 01/2018
1	Membrane Proteins (Integral Membrane Proteins)IBA 01/2017

Therapy/Procedure

2	Therapeutics 10/2023 - 01/2017
1	Aftercare (After-Treatment) 04/2021